PyInvesting

Market research

BUWA.F Bio-Rad Laboratories, Inc

F EUR Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
9B
P/E ratio
45.16
Analyst target
856.25
Dividend yield
Not available
Beta
1.07

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Bio-Rad Laboratories, Inc is currently in a long term uptrend where the price is trading 16.0% above its 200 day moving average.

From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.8.

Bio-Rad Laboratories, Inc's total revenue rose by 26.5% to $790M since the same quarter in the previous year.

Its net income has increased by 51.6% to $839M since the same quarter in the previous year.

Finally, its free cash flow grew by 77.6% to $245M since the same quarter in the previous year.

Based on the above factors, Bio-Rad Laboratories, Inc gets an overall score of 5/5.